Study Examines Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 23, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2020.0311?guestAccessKey=fdbc1d49-7abc-434f-9309-9983b8a38ca5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032320

 

What The Study Did: This study used data and brain imaging from a randomized clinical trial for older adults who are cognitively unimpaired and examined brain changes, including the presence of biomarkers for Alzheimer disease, between those with sleep-disordered breathing and those without.

Authors: Gael Chetelat, Ph.D., of the Universite de Caen in France, is the corresponding author.

 

(doi:10.1001/jamaneurol.2020.0311)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.